Cargando…
Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
The diversity and heterogeneity within high-grade serous ovarian cancer (HGSC), which is the most lethal gynecologic malignancy, is not well understood. Here, we perform comprehensive multi-platform omics analyses, including integrated analysis, and immune monitoring on primary and metastatic sites...
Ejemplares similares
-
Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients
por: Bateman, Nicholas W., et al.
Publicado: (2021) -
Jupiter microtubule‐associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers
por: Bateman, Nicholas W., et al.
Publicado: (2019) -
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry
por: Bateman, Nicholas W., et al.
Publicado: (2021) -
Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues
por: Penick, Emily R., et al.
Publicado: (2022) -
From Discovery to Practice and Survivorship: Building a National Real‐World Data Learning Healthcare Framework for Military and Veteran Cancer Patients
por: Lee, Jerry S. H., et al.
Publicado: (2019)